Literature DB >> 17996297

Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine.

Xing-Xiang Peng1, Zhi Shi, Vijaya L Damaraju, Xiao-Cong Huang, Gary D Kruh, Hsiang-Chun Wu, Ying Zhou, Amit Tiwari, Liwu Fu, Carol E Cass, Zhe-Sheng Chen.   

Abstract

To investigate the mechanism of cellular resistance to 6-MP, we established a 6-MP resistant cell line (CEM-MP5) by stepwise selection of the human T-lymphoblastic leukemia cell line (CEM). CEM-MP5 cells were about 100-fold resistant to 6-MP compared with parental CEM cells. Western blot analysis demonstrated that multidrug resistant protein 4 (MRP4) was increased in CEM-MP5 cells, whereas the levels of the nucleoside transporters hENT1, hCNT2 and hCNT3 were decreased compared with those of parental CEM cells. Consistent with the operation of an efflux pump, accumulation of [14C]6-MP and/or its metabolites was reduced, and ATP-dependent efflux was increased in CEM-MP5 cells. Taken together these results showed that up-regulation of MRP4 and down-regulation of influx transporters played a major role in 6-MP resistance of CEM-MP5 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996297     DOI: 10.1016/j.leukres.2007.09.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  23 in total

Review 1.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

2.  Transporter-mediated protection against thiopurine-induced hematopoietic toxicity.

Authors:  Partha Krishnamurthy; Matthias Schwab; Kazumasa Takenaka; Deepa Nachagari; Jessica Morgan; Mark Leslie; Weinan Du; Kelli Boyd; Meyling Cheok; Hiromitsu Nakauchi; Catia Marzolini; Richard B Kim; Balasubramanian Poonkuzhali; Erin Schuetz; William Evans; Mary Relling; John D Schuetz
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

3.  Mechanisms of NT5C2-Mediated Thiopurine Resistance in Acute Lymphoblastic Leukemia.

Authors:  Takaya Moriyama; Shuguang Liu; Jing Li; Julia Meyer; Xujie Zhao; Wentao Yang; Youming Shao; Richard Heath; Aleš Hnízda; William L Carroll; Jun J Yang
Journal:  Mol Cancer Ther       Date:  2019-07-29       Impact factor: 6.261

4.  Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity.

Authors:  Chengcheng Liu; Laura J Janke; Jun J Yang; William E Evans; John D Schuetz; Mary V Relling
Journal:  Cancer Chemother Pharmacol       Date:  2017-06-16       Impact factor: 3.333

5.  Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.

Authors:  Y Tanaka; A Manabe; H Fukushima; R Suzuki; H Nakadate; K Kondoh; K Nakamura; K Koh; T Fukushima; M Tsuchida; K Koike; N Kiyokawa; E Noguchi; R Sumazaki; T Komiyama
Journal:  Pharmacogenomics J       Date:  2014-11-18       Impact factor: 3.550

6.  The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Authors:  Hiromistu Ban; Akira Andoh; Hirotsugu Imaeda; Ayako Kobori; Shigeki Bamba; Tomoyuki Tsujikawa; Masaya Sasaki; Yasuharu Saito; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2010-10       Impact factor: 7.527

7.  Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.

Authors:  Elena Sjuvarsson; Vijaya L Damaraju; Delores Mowles; Michael B Sawyer; Rohit Tiwari; Hitesh K Agarwal; Ahmed Khalil; Sherifa Hasabelnaby; Ayman Goudah; Robin J Nakkula; Rolf F Barth; Carol E Cass; Staffan Eriksson; Werner Tjarks
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

8.  Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Authors:  Rie Osaki; Hirotsugu Imaeda; Hiromitsu Ban; Tomoki Aomatsu; Shigeki Bamba; Tomoyuki Tsujikawa; Masaya Sasaki; Yoshihide Fujiyama; Akira Andoh
Journal:  Exp Ther Med       Date:  2011-06-16       Impact factor: 2.447

9.  Retention of metabolites of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel anti-human immunodeficiency virus type 1 thymidine analog, in cells.

Authors:  Xin Wang; Hiromichi Tanaka; Masanori Baba; Yung-chi Cheng
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

10.  Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression.

Authors:  Matteo Montani; Thomas Hermanns; Thomas Herrmanns; Michael Müntener; Peter Wild; Tullio Sulser; Glen Kristiansen
Journal:  Virchows Arch       Date:  2013-03-16       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.